Email updates

Keep up to date with the latest news and content from BMC Genetics and BioMed Central.

Open Access Highly Accessed Methodology article

Simultaneous quantitative and allele-specific expression analysis with real competitive PCR

Chunming Ding1*, Esther Maier2, Adelbert A Roscher2, Andreas Braun3 and Charles R Cantor13*

Author Affiliations

1 Bioinformatics Program and Center for Advanced Biotechnology, Boston University, Boston, MA 02215 USA

2 Children's Hospital, University of Munich, Lindwurmstrasse 4, 80337 Munich, Germany

3 SEQUENOM, Inc., San Diego, CA 92121 USA

For all author emails, please log on.

BMC Genetics 2004, 5:8  doi:10.1186/1471-2156-5-8

Published: 5 May 2004

Abstract

Background

For a diploid organism such as human, the two alleles of a particular gene can be expressed at different levels due to X chromosome inactivation, gene imprinting, different local promoter activity, or mRNA stability. Recently, imbalanced allelic expression was found to be common in human and can follow Mendelian inheritance. Here we present a method that employs real competitive PCR for allele-specific expression analysis.

Results

A transcribed mutation such as a single nucleotide polymorphism (SNP) is used as the marker for allele-specific expression analysis. A synthetic mutation created in the competitor is close to a natural mutation site in the cDNA sequence. PCR is used to amplify the two cDNA sequences from the two alleles and the competitor. A base extension reaction with a mixture of ddNTPs/dNTP is used to generate three oligonucleotides for the two cDNAs and the competitor. The three products are identified and their ratios are calculated based on their peak areas in the MALDI-TOF mass spectrum. Several examples are given to illustrate how allele-specific gene expression can be applied in different biological studies.

Conclusions

This technique can quantify the absolute expression level of each individual allele of a gene with high precision and throughput.

Keywords:
allele-specific; gene expression; MALDI-TOF mass spectrometry; PCR; heterozygous